An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A reader reports they used Wegovy (a prescription weight-loss drug) starting in July 2023, titrated up slowly and stopping at a 1.7 mg dose because higher doses caused stomach pain around injection days. They later switched to Zepbound and liked it because it had fewer side effects. Recently they were diagnosed with gastroparesis (a condition where the stomach empties more slowly than normal), and they’re describing their timeline and symptoms. Wegovy contains semaglutide, which is a man-made version of a naturally occurring gut hormone. That hormone helps regulate appetite and how fast your stomach empties. In plain terms, semaglutide tells your brain you’re less hungry and can slow the movement of food through your stomach, which is part of how it helps people lose weight. The person’s report is an individual anecdote, not a controlled study. It tells us only that they had stomach pain while titrating Wegovy and later developed gastroparesis after using it for a few years and switching drugs. Anecdotes can highlight possible links worth studying, but they don’t prove cause and effect. Clinical trials and broader studies are needed to tell whether semaglutide or similar drugs increase the risk of gastroparesis in the general population, and if so, how often. Why this matters: millions of people use GLP-1 drugs like Wegovy and similar medications for weight management or diabetes. Gastroparesis causes nausea, vomiting, bloating, and poor nutrient absorption, and can seriously affect quality of life. If these drugs can trigger or worsen delayed stomach emptying in some people, that would be important for patients and doctors to know so they can watch for symptoms and adjust treatment if needed. Caveats and risks: this is a single-person account, so it doesn’t prove the drug caused the problem. Gastroparesis has many causes (diabetes, surgeries, infections, neurological conditions, medications), and the snippet doesn’t give full medical details. Known side effects of GLP-1 drugs include nausea, stomach discomfort, and slowed gastric emptying in some people — symptoms that can overlap with gastroparesis. Anyone on these medications who develops persistent nausea, vomiting, or inability to tolerate food should talk to their doctor. Don’t stop prescribed medication abruptly without medical advice. Bottom line: an individual who used Wegovy and later developed gastroparesis raises a flag worth clinical attention, but one story doesn’t prove the drugs are to blame — more research and medical evaluation are needed.
Source: r/Semaglutide